Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Critical care nurses' experiences of providing care for adults in a highly technological environment: A qualitative evidence synthesis.

Crilly G, Dowling M, Delaunois I, Flavin M, Biesty L.

J Clin Nurs. 2019 Aug 20. doi: 10.1111/jocn.15043. [Epub ahead of print] Review.

PMID:
31429996
2.

Are observed associations between a high maternal prepregnancy body mass index and offspring IQ likely to be causal?

Coo H, Fabrigar L, Davies G, Fitzpatrick R, Flavin M.

J Epidemiol Community Health. 2019 Oct;73(10):920-928. doi: 10.1136/jech-2019-212257. Epub 2019 Jul 29.

PMID:
31358534
3.

Weekend Admission to Inpatient Rehabilitation Facilities is Associated with Transfer to Acute Care in a Nationwide Sample of Patients with Stroke.

Shih SL, Flavin M, Goldstein R, Slocum C, Ryan CM, Singhal A, Frankel J, Zafonte R, Schneider JC.

Am J Phys Med Rehabil. 2019 Jul 15. doi: 10.1097/PHM.0000000000001266. [Epub ahead of print]

PMID:
31335342
4.

Hormonal Contraceptive Prescription in Young Women With Cerebral Palsy.

Flavin M, Shore BJ, Miller P, Gray S.

J Adolesc Health. 2019 Sep;65(3):405-409. doi: 10.1016/j.jadohealth.2019.03.010. Epub 2019 Jun 24.

PMID:
31248805
5.

Bridging the gap in genetics: a progressive model for primary to specialist care.

Harding B, Webber C, Rühland L, Dalgarno N, Armour C, Birtwhistle R, Brown G, Carroll JC, Flavin M, Phillips SP, MacKenzie JJ.

BMC Med Educ. 2019 Jun 11;19(1):195. doi: 10.1186/s12909-019-1622-y.

6.

High resolution crystal structure of the FAK FERM domain reveals new insights on the Druggability of tyrosine 397 and the Src SH3 binding site.

Marlowe T, Dementiev A, Figel S, Rivera A, Flavin M, Cance W.

BMC Mol Cell Biol. 2019 May 20;20(1):10. doi: 10.1186/s12860-019-0193-4.

7.

Hypoglycemia in unmonitored full-term newborns-a surveillance study.

Flavin MP, Osiovich H, Coughlin K, Sgro M, Ray J, Hu L, León JA, Gregoire K, Barr L, Gallipoli A, Grewal K.

Paediatr Child Health. 2018 Dec;23(8):509-514. doi: 10.1093/pch/pxy025. Epub 2018 Mar 10.

PMID:
30842696
8.

Interpregnancy Intervals in a Contemporary Manitoba Cohort: Prevalence of So-Called Suboptimal Intervals and Associated Maternal Characteristics.

Coo H, Brownell MD, Ruth C, Flavin M, Au W, Day AG.

J Obstet Gynaecol Can. 2018 Aug;40(8):1024-1030. doi: 10.1016/j.jogc.2017.12.001.

PMID:
30103875
9.

Predictors of Postoperative Rehabilitation Therapy Following Congenital Heart Surgery.

Ubeda Tikkanen A, Nathan M, Sleeper LA, Flavin M, Lewis A, Nimec D, Mayer JE, Del Nido P.

J Am Heart Assoc. 2018 May 12;7(10). pii: e008094. doi: 10.1161/JAHA.117.008094.

10.

Primary care providers' lived experiences of genetics in practice.

Harding B, Webber C, Ruhland L, Dalgarno N, Armour CM, Birtwhistle R, Brown G, Carroll JC, Flavin M, Phillips S, MacKenzie JJ.

J Community Genet. 2019 Jan;10(1):85-93. doi: 10.1007/s12687-018-0364-6. Epub 2018 Apr 26.

11.

[Selective left mainstem bronchial intubation in the neonatal intensive care unit].

Ho AMH, Flavin MP, Fleming ML, Mizubuti GB.

Rev Bras Anestesiol. 2018 May - Jun;68(3):318-321. doi: 10.1016/j.bjan.2017.04.016. Epub 2018 Apr 13. Portuguese.

12.

Structures of human plasma β-factor XIIa cocrystallized with potent inhibitors.

Dementiev A, Silva A, Yee C, Li Z, Flavin MT, Sham H, Partridge JR.

Blood Adv. 2018 Mar 13;2(5):549-558. doi: 10.1182/bloodadvances.2018016337.

13.

Interpregnancy Interval and Congenital Anomalies: A Record-Linkage Study Using the Manitoba Population Research Data Repository.

Coo H, Brownell MD, Ruth C, Flavin M, Au W, Day AG.

J Obstet Gynaecol Can. 2017 Nov;39(11):996-1007. doi: 10.1016/j.jogc.2017.04.039. Epub 2017 Jul 28.

PMID:
28757407
14.

Esophageal Atresia/Tracheoesophageal Fistula Repair Complicated by Tracheomalacia: A Case Report of Successful Management of Respiratory Distress Using Caudal Morphine.

Dion JM, Ho AM, Winthrop A, Flavin MP.

A A Case Rep. 2017 Jul 1;9(1):28-30. doi: 10.1213/XAA.0000000000000517.

PMID:
28410264
15.

Interpregnancy Interval and Adverse Perinatal Outcomes: A Record-Linkage Study Using the Manitoba Population Research Data Repository.

Coo H, Brownell MD, Ruth C, Flavin M, Au W, Day AG.

J Obstet Gynaecol Can. 2017 Jun;39(6):420-433. doi: 10.1016/j.jogc.2017.01.010. Epub 2017 Mar 28.

PMID:
28363608
16.

Patient perspectives on ipilimumab across the melanoma treatment trajectory.

Shuk E, Shoushtari AN, Luke J, Postow MA, Callahan M, Harding JJ, Roth KG, Flavin M, Granobles A, Christian J, Gold G, Schoenhammer M, Gordon M, Cimaglia N, Dyson R, Goodman-Davis N, Colgan MN, Jefferson IS, Munhoz R, D'Angelo S, Wolchok J, Chapman P, Chi P, Carvajal RD, Hay JL.

Support Care Cancer. 2017 Jul;25(7):2155-2167. doi: 10.1007/s00520-017-3621-z. Epub 2017 Mar 1.

17.

Effect of Picture Archiving and Communication System Image Manipulation on the Agreement of Chest Radiograph Interpretation in the Neonatal Intensive Care Unit.

Castro DA, Naqvi AA, Vandenkerkhof E, Flavin MP, Manson D, Soboleski D.

J Clin Imaging Sci. 2016 May 19;6:19. doi: 10.4103/2156-7514.182730. eCollection 2016.

18.

Severe Pediatric Bronchomalacia.

Ho AM, Winthrop A, Jones EF, Flavin MP.

Anesthesiology. 2016 Jun;124(6):1395. doi: 10.1097/ALN.0000000000000989. No abstract available.

PMID:
26682632
19.

Novel Method to Improve Radiologist Agreement in Interpretation of Serial Chest Radiographs in the ICU.

Castro DA, Naqvi AA, Manson D, Flavin MP, VanDenKerkhof E, Soboleski D.

J Clin Imaging Sci. 2015 Jul 31;5:39. doi: 10.4103/2156-7514.161848. eCollection 2015.

20.

The association between the interpregnancy interval and autism spectrum disorder in a Canadian cohort.

Coo H, Ouellette-Kuntz H, Lam YM, Brownell M, Flavin MP, Roos LL.

Can J Public Health. 2015 Feb 3;106(2):e36-42. doi: 10.17269/cjph.106.4667.

21.

Soft network composite materials with deterministic and bio-inspired designs.

Jang KI, Chung HU, Xu S, Lee CH, Luan H, Jeong J, Cheng H, Kim GT, Han SY, Lee JW, Kim J, Cho M, Miao F, Yang Y, Jung HN, Flavin M, Liu H, Kong GW, Yu KJ, Rhee SI, Chung J, Kim B, Kwak JW, Yun MH, Kim JY, Song YM, Paik U, Zhang Y, Huang Y, Rogers JA.

Nat Commun. 2015 Mar 18;6:6566. doi: 10.1038/ncomms7566.

22.

Impact of NRAS mutations for patients with advanced melanoma treated with immune therapies.

Johnson DB, Lovly CM, Flavin M, Panageas KS, Ayers GD, Zhao Z, Iams WT, Colgan M, DeNoble S, Terry CR, Berry EG, Iafrate AJ, Sullivan RJ, Carvajal RD, Sosman JA.

Cancer Immunol Res. 2015 Mar;3(3):288-295. doi: 10.1158/2326-6066.CIR-14-0207.

23.

Hypoglycemia in an unmonitored full-term newborn.

Flavin M, Maguire J.

Paediatr Child Health. 2015 Jan-Feb;20(1):52. No abstract available.

24.

Materials science. Assembly of micro/nanomaterials into complex, three-dimensional architectures by compressive buckling.

Xu S, Yan Z, Jang KI, Huang W, Fu H, Kim J, Wei Z, Flavin M, McCracken J, Wang R, Badea A, Liu Y, Xiao D, Zhou G, Lee J, Chung HU, Cheng H, Ren W, Banks A, Li X, Paik U, Nuzzo RG, Huang Y, Zhang Y, Rogers JA.

Science. 2015 Jan 9;347(6218):154-9. doi: 10.1126/science.1260960.

25.

Canadian paediatric asthma action plans and their correlation with current consensus guidelines.

MacGillivray ME, Flavin MP.

Paediatr Child Health. 2014 Aug;19(7):362-6.

26.

Soft microfluidic assemblies of sensors, circuits, and radios for the skin.

Xu S, Zhang Y, Jia L, Mathewson KE, Jang KI, Kim J, Fu H, Huang X, Chava P, Wang R, Bhole S, Wang L, Na YJ, Guan Y, Flavin M, Han Z, Huang Y, Rogers JA.

Science. 2014 Apr 4;344(6179):70-4. doi: 10.1126/science.1250169.

27.

Combating multidrug-resistant Gram-negative bacterial infections.

Xu ZQ, Flavin MT, Flavin J.

Expert Opin Investig Drugs. 2014 Feb;23(2):163-82. doi: 10.1517/13543784.2014.848853. Epub 2013 Nov 11. Review.

PMID:
24215473
28.

Impact of hyperthermia on inflammation-related perinatal brain injury.

Seri L, Rossiter JP, MacNair L, Flavin MP.

Dev Neurosci. 2012;34(6):525-32. doi: 10.1159/000345966. Epub 2013 Feb 14.

29.

Efficacy of post exposure administration of doxycycline in a murine model of inhalational melioidosis.

Gelhaus HC, Anderson MS, Fisher DA, Flavin MT, Xu ZQ, Sanford DC.

Sci Rep. 2013;3:1146. doi: 10.1038/srep01146. Epub 2013 Jan 28.

30.

Methylenedioxy- and ethylenedioxy-fused indolocarbazoles: potent human topoisomerase I inhibitors and antitumor agents.

Zembower DE, Xie Y, Koohang A, Kuffel MJ, Ames MM, Zhou Y, Mishra R, Mar AA, Flavin MT, Xu ZQ.

Anticancer Agents Med Chem. 2012 Nov;12(9):1117-31.

PMID:
22339065
31.

Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies.

English ML, Fredericks CE, Milanesio NA, Rohowsky N, Xu ZQ, Jenta TR, Flavin MT, Eiznhamer DA.

Antimicrob Agents Chemother. 2012 Apr;56(4):2037-47. doi: 10.1128/AAC.05596-11. Epub 2012 Jan 30.

32.

Treatment of locally recurrent mucosal melanoma with topical imiquimod.

Smyth EC, Flavin M, Pulitzer MP, Gardner GJ, Costantino PD, Chi DS, Bogatch K, Chapman PB, Wolchok JD, Schwartz GK, Carvajal RD.

J Clin Oncol. 2011 Nov 20;29(33):e809-11. doi: 10.1200/JCO.2011.36.8829. Epub 2011 Oct 17. No abstract available.

PMID:
22010009
33.

Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells.

Butler MO, Friedlander P, Milstein MI, Mooney MM, Metzler G, Murray AP, Tanaka M, Berezovskaya A, Imataki O, Drury L, Brennan L, Flavin M, Neuberg D, Stevenson K, Lawrence D, Hodi FS, Velazquez EF, Jaklitsch MT, Russell SE, Mihm M, Nadler LM, Hirano N.

Sci Transl Med. 2011 Apr 27;3(80):80ra34. doi: 10.1126/scitranslmed.3002207.

34.

Effect of inhaled hypertonic saline on hospital admission rate in children with viral bronchiolitis: a randomized trial.

Kuzik BA, Flavin MP, Kent S, Zielinski D, Kwan CW, Adeleye A, Vegsund BC, Rossi C.

CJEM. 2010 Nov;12(6):477-84.

PMID:
21073773
35.

Synthesis, proapoptotic screening, and structure-activity relationships of novel aza-lupane triterpenoids.

Mar AA, Szotek EL, Koohang A, Flavin WP, Eiznhamer DA, Flavin MT, Xu ZQ.

Bioorg Med Chem Lett. 2010 Sep 15;20(18):5389-93. doi: 10.1016/j.bmcl.2010.07.120. Epub 2010 Aug 3.

PMID:
20719505
36.

Diffusion MRI brain findings in neonates exposed to chorioamnionitis: a case series.

Gaudet LM, Flavin M, Islam O, Smith GN.

J Obstet Gynaecol Can. 2009 Jun;31(6):497-503.

PMID:
19646314
37.

Synthesis and cytotoxicity of 2-cyano-28-hydroxy-lup-1-en-3-ones.

Koohang A, Majewski ND, Szotek EL, Mar AA, Eiznhamer DA, Flavin MT, Xu ZQ.

Bioorg Med Chem Lett. 2009 Apr 15;19(8):2168-71. doi: 10.1016/j.bmcl.2009.02.107. Epub 2009 Mar 3.

PMID:
19286375
38.

Hyperthermia amplifies brain cytokine and reactive oxygen species response in a model of perinatal inflammation.

Wang W, Dow KE, Flavin MP.

Neurosci Lett. 2008 Nov 21;445(3):233-5. doi: 10.1016/j.neulet.2008.08.088. Epub 2008 Sep 11.

PMID:
18801411
39.

Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants.

Kuzik BA, Al-Qadhi SA, Kent S, Flavin MP, Hopman W, Hotte S, Gander S.

J Pediatr. 2007 Sep;151(3):266-70, 270.e1. Epub 2007 Jun 29.

PMID:
17719935
40.

Stages of development and injury patterns in the early years: a population-based analysis.

Flavin MP, Dostaler SM, Simpson K, Brison RJ, Pickett W.

BMC Public Health. 2006 Jul 18;6:187.

41.

Pyranocoumarin, a novel anti-TB pharmacophore: synthesis and biological evaluation against Mycobacterium tuberculosis.

Xu ZQ, Pupek K, Suling WJ, Enache L, Flavin MT.

Bioorg Med Chem. 2006 Jul 1;14(13):4610-26. Epub 2006 Mar 2.

PMID:
16513358
42.

A comparison of high and standard blood transfusion volumes in premature infants.

Wong H, Connelly R, Day A, Flavin MP.

Acta Paediatr. 2005 May;94(5):624-5.

PMID:
16188753
43.

Nature of the accessible chromatin at a glucocorticoid-responsive enhancer.

Flavin M, Cappabianca L, Kress C, Thomassin H, Grange T.

Mol Cell Biol. 2004 Sep;24(18):7891-901.

44.

Effective attenuation of endotoxin-induced acute lung injury by 2,3-diacetyloxybenzoic acid in two independent animal models.

Eiznhamer DA, Flavin MT, Jesmok GJ, Borgia JF, Nelson DJ, Burhop KE, Xu ZQ.

Pulm Pharmacol Ther. 2004;17(2):105-10.

PMID:
15123232
45.

Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.

Xu ZQ, Barrow WW, Suling WJ, Westbrook L, Barrow E, Lin YM, Flavin MT.

Bioorg Med Chem. 2004 Mar 1;12(5):1199-207.

PMID:
14980631
46.
47.

Safety and pharmacokinetic profile of multiple escalating doses of (+)-calanolide A, a naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy HIV-negative volunteers.

Eiznhamer DA, Creagh T, Ruckle JL, Tolbert DT, Giltner J, Dutta B, Flavin MT, Jenta T, Xu ZQ.

HIV Clin Trials. 2002 Nov-Dec;3(6):435-50.

PMID:
12501127
48.

Coumarins and pyranocoumarins, potential novel pharmacophores for inhibition of measles virus replication.

Barnard DL, Xu Ze, Stowell VD, Yuan H, Smee DF, Samy R, Sidwell RW, Nielsen MK, Sun L, Cao H, Li A, Quint C, Deignan J, Crabb J, Flavin MT.

Antivir Chem Chemother. 2002 Jan;13(1):39-59.

PMID:
12180648
49.

Chalcones and flavonoids as anti-tuberculosis agents.

Lin YM, Zhou Y, Flavin MT, Zhou LM, Nie W, Chen FC.

Bioorg Med Chem. 2002 Aug;10(8):2795-802.

PMID:
12057669
50.

Amyloid fibril formation in microwell plates for screening of inhibitors.

Lin YM, Raffen R, Zhou Y, Cassidy CS, Flavin MT, Stevens FJ.

Amyloid. 2001 Sep;8(3):182-93.

PMID:
11676295

Supplemental Content

Loading ...
Support Center